Home/Filings/4/0001576280-25-000209
4//SEC Filing

Eltoukhy Helmy 4

Accession 0001576280-25-000209

CIK 0001576280other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 9:16 PM ET

Size

13.5 KB

Accession

0001576280-25-000209

Insider Transaction Report

Form 4
Period: 2025-06-30
Eltoukhy Helmy
DirectorCo-Chief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-07-01+23,9972,435,661 total
  • Tax Payment

    Common Stock

    2025-06-30$52.04/sh2,441$127,0302,411,664 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-06-304,8159,629 total
    Exercise: $0.00Common Stock (4,815 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-30+4,8152,414,105 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-07-0123,997143,983 total
    Exercise: $0.00Common Stock (23,997 underlying)
  • Tax Payment

    Common Stock

    2025-07-01$50.71/sh12,162$616,7352,423,499 total
Footnotes (4)
  • [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
  • [F2]This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
  • [F3]Not applicable for Restricted Stock Units.
  • [F4]This restricted stock unit award vested with respect to 1/3 of the shares on January 1, 2025. The remaining shares vest quarterly for the remaining twenty-four months.

Issuer

Guardant Health, Inc.

CIK 0001576280

Entity typeother

Related Parties

1
  • filerCIK 0001752968

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 9:16 PM ET
Size
13.5 KB